ResearchAndMarkets adds efzofitimod sales forecast through 2034
AI Summary- ResearchAndMarkets.com added an efzofitimod sales and market-size forecast report through 2034.
- 268 patients enrolled across 85 sites in nine countries in the EFZO-FIT Phase III study.
- Efzofitimod remains under clinical investigation and has not received regulatory approval.